Two MAD tails: What the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1423, Issue 3, 1999, Pages

  Foley, Kevin P ^a,b   Eisenman, Robert N ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b ZYMOGENETICS INC   (United States)

Author keywords

Cancer; Knockout mouse; MAD; MAX; MYC; Targeted gene disruption; Transcriptional repression; Tumor suppressor; Tumorigenesis

Indexed keywords

MAX PROTEIN; ONCOPROTEIN; PROTEIN MAD1; PROTEIN MXI1; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER INHIBITION; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN STRUCTURE; DIMERIZATION; GENE DELETION; KNOCKOUT GENE; MOUSE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN FAMILY; PROTO ONCOGENE; SHORT SURVEY;

ANIMALIA;

EID: 0033620609     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-419X(99)00012-8     Document Type: Review

References (70)

1. G.A. McArthur, C.D. Laherty, C. Quéva, P.J. Hurlin, L. Loo, L. James, C. Grandori, P. Gallant, Y. Shiio, W.C. Hokanson, A.C. Bush, P.F. Cheng, Q. Lawrence, B. Pulverer, P.J. Koskinen, K.P. Foley, D.E. Ayer, R.N. Eisenman, The Mad protein family links transcriptional repression to cell differentiation. Cold Spring Harbor Symp. Quant. Biol. 63, 1998, in press.
2. N. Schreiber-Agus, R.A. DePinho, Repression by the Mad(Mxil)-Sin3 complex, BioEssays 20 (1998) 808-818.
3. D.E. Ayer, L. Kretzner, R.N. Eisenman, Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity, Cell 72 (1993) 211-222.
4. A.S. Zervos, J. Gyuris, R. Brent, Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites, Cell 72 (1993) 223-232.
5. P.J. Hurlin, C. Quéva, P.J. Koskinen, E. Steingrímsson, D.E. Ayer, N.G. Copeland, N.A. Jenkins, R.N. Eisenman, Mad3 and Mad4: Novel Max-interacting transcriptional repressors that suppress c-Myc-dependent transformation and are expressed during neural and epidermal differentiation, EMBO J. 14 (1995) 5646-5659.
6. E.M. Blackwood, R.N. Eisenman, Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA binding complex with Myc, Science 251 (1991) 1211-1217.
7. A.R. Ferre-D'Amare, G.C. Prendergast, E.B. Ziff, S.K. Burley, Recognition of Max by its cognate DNA through a dimeric b/HLH/Z domain, Nature 363 (1993) 38-46.
8. T.K. Blackwell, J. Huang, A. Ma, L. Kretzner, F.W. Alt, R.N. Eisenman, H. Weintraub, Binding of Myc proteins to canonical and noncanonical DNA sequences, Mol. Cell. Biol. 13 (1993) 5216-5224.
9. P. Hurlin, C. Queva, R.N. Eisenman, Mnt, a novel Maxinteracting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites, Genes Dev. 11 (1997) 44-58.
10. E.M. Blackwood, B. Luscher, R.N. Eisenman, Myc and Max associate in vivo, Genes Dev. 6 (1992) 71-80.
11. D.E. Ayer, R.N. Eisenman, A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation, Genes Dev. 7 (1993) 2110-2119.
12. B. Amati, H. Land, Myc-Max-Mad : a transcription factor network controlling cell cycle progression, differentiation and death, Curr. Opin. Genet. Dev. 4 (1994) 102-108.
13. G.J. Kato, J. Barrett, M. Villa-Garcia, C.V. Dang, An amino-terminal c-Myc domain required for neoplastic transformation activates transcription, Mol. Cell. Biol. 10 (1990) 5914-5920.
14. L. Kretzner, E.M. Blackwood, R.N. Eisenman, The Myc and Max proteins possess distinct transcriptional activities, Nature 359 (1992) 426-429.
15. B. Amati, S. Dalton, M.W. Brooks, T.D. Littlewood, G.I. Evan, H. Land, Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max, Nature 359 (1992) 423-426.
16. L.-G. Larsson, M. Pettersson, F. Öberg, K. Nilsson, B. Lüscher, Expression of mad, mxil, max, and c-myc during induced differentiation of hematopoietic cells : opposite regulation of mad and c-myc, Oncogene 9 (1994) 1247-1252.
17. I. Vastrik, A. Kaipainen, T.-L. Penttila, A. Lymboussakis, R. Alitalo, M. Parvinen, K. Alitalo, Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro, J. Cell Biol. 128 (1995) 1197-1208.
18. P.J. Hurlin, K.P. Foley, D.E. Ayer, R.N. Eisenman, D. Hanahan, J.M. Arbeit, Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis, Oncogene 11 (1995) 2487-2501.
19. A. Gandarillas, F.M. Watt, Changes in expression of members of the fos and jun families and myc network during normal terminal differentiation of keratinocytes, Oncogene 11 (1995) 1403-1407.
20. A. Lymboussaki, A. Kaipainen, E. Hatva, I. Vastrik, M. Jeskanen, S. Werner, F. Stenback, R. Alitalo, Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin, Br. J. Cancer 73 (1996) 1347-1355.
21. C. Queva, P.J. Hurlin, K.P. Foley, R.N. Eisenman, Sequential expression of the MAD family of transcriptional repressers during differentiation, Oncogene 16 (1998) 967-977.
22. C.M. Cultraro, T. Bino, S. Segal, Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation, Mol. Cell. Biol. 17 (1997) 2353-2359.
23. K.P. Foley, G.A. McArthur, C. Quéva, P.J. Hurlin, P. Soriano, R.N. Eisenman, Targeted disruption of Mad1 inhibits cell cycle exit during granulocyte differentiation, EMBO J. 17 (1998) 774-785.
24. M. Henriksson, B. Luscher, Proteins of the Myc network: essential regulators of cell growth and differentiation, Adv. Cancer Res. 68 (1996) 109-182.
25. E.G. Lahoz, L. Xu, N. Schreiber-Agus, R.A. DePinho, Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxil, Proc. Natl. Acad. Sci. USA 91 (1994) 5503-5507.
26. C. Cerni, K. Bousset, C. Seelos, H. Burkhardt, M. Henriksson, B. Luscher, Differential effects by Mad and Max on transformation by cellular and viral oncoproteins, Oncogene 11 (1995) 587-596.
27. J. Chen, T. Willingham, L.R. Margraf, N. Schreiber-Agus, R.A. DePinho, P.D. Nisen, Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumor cells, Nature Med. 1 (1995) 638-643.
28. P.J. Koskinen, D.E. Ayer, R.N. Eisenman, Repression of Myc-Ras co-transformation by Mad is mediated by multiple protein-protein interactions, Cell Growth Differ. 6 (1995) 623-629.
29. M.F. Roussel, R.A. Ashmun, C.J. Sherr, R.N. Eisenman, D.E. Ayer, Inhibition of cell proliferation by the Mad1 transcriptional represser, Mol. Cell. Biol. 16 (1996) 2796-2801.
30. B. Roy, D. Reisman, Inducible expression of Mad accelerates growth arrest of serum deprived human glioblastoma cells, Cell. Biol. Int. 19 (1995) 307-313.
31. D.S. Wechsler, C.A. Shelly, C.A. Petroff, C.V. Dang, MXIl, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells, Cancer Res. 57 (1997) 4905-4912.
32. K. Berns, E.M. Hijmans, R. Bernards, Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity, Oncogene 15 (1997) 1347-1356.
33. S. Edelhoff, D.E. Ayer, A.S. Zervos, E. Steingrimsson, N.A. Jenkins, N.G. Copeland, R.N. Eisenman, R. Brent, C.M. Disteche, Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXIl to human chromosome 10 and mouse chromosome 19, Oncogene 9 (1994) 665-668.
34. L.R. Eagle, X. Yin, A.R. Brothman, B.J. Williams, N.B. Atkin, E.V. Prochownik, Mutation of the MXIl gene in prostate cancer, Nature Genet. 9 (1995) 249-255.
35. E.V. Prochownik, L.E. Grove, D. Deubler, X.L. Zhu, R.A. Stephenson, L.R. Rohr, X. Yin, A.R. Brothman, Commonly occurring loss and mutation of the MXIl gene in prostate cancer, Genes Chromosomes Cancer 22 (1998) 295-304.
36. I.C. Gray, S.M.A. Phillips, S.J. Lee, J.P. Neoptolemos, J. Weissenbach, N.K. Spurr, Loss of the chromosomal region 10q23-25 in prostate cancer, Cancer Res. 55 (1995) 4800-4803.
37. S. Peterson, G. Wolf, U. Bockmühl, K. Gellert, I. Peterson, Allelic loss on chromosome 10q in human lung cancer: association with tumor progression and metastatic phenotype, Br. J. Cancer 77 (1998) 270-276.
38. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, S.I. Wang, J. Puc, C. Miliaresis, L. Rodgers, R. McCombie, S.H. Bigner, B.C. Giocanella, M. Ittmann, B. Tycko, H. Hibshoosh, M.H. Wigler, R. Parsons, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer, Science 275 (1997) 1943-1947.
39. D.E. Ayer, Q.A. Lawrence, R.N. Eisenman, Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3, Cell 80 (1995) 767-776.
40. N. Schreiber-Agus, L. Chin, K. Chen, R. Torres, G. Rao, P. Guida, A.I. Skoultchi, R.A. DePinho, An amino-terminal domain of Mxil mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast repressor SIN3, Cell 80 (1995) 777-786.
41. D.E. Ayer, C.D. Laherty, Q.A. Lawrence, A.P. Armstrong, R.N. Eisenman, Mad proteins contain a dominant transcription repression domain, Mol. Cell. Biol. 16 (1996) 5772-5781.
42. L. Alland, R. Muhle, H. Hou Jr., J. Potes, L. Chin, N. Schreiber-Agus, R.A. DePinho, Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression, Nature 387 (1997) 49-55.
43. C.A. Hassig, T.C. Fleischer, A.N. Billin, S.L. Schreiber, D.E. Ayer, Histone deacetylase activity is required for full transcriptional repression by mSin3A, Cell 89 (1997) 341-347.
44. T. Heinzel, R.M. Lavinsky, T.-M. Mullen, M. Söderström, C.D. Laherty, J. Torchia, W.-M. Yang, G. Brard, S.G. Ngo, J.R. Davie, E. Seto, R.N. Eisenman, D.W. Rose, C.K. Glass, M.G. Rosenfeld, N-CoR, mSin3, and histone deacetylase-containing complexes in nuclear receptor and Mad repression, Nature 387 (1997) 43-48.
45. C.D. Laherty, W.-M. Yang, J.-M. Sun, J.R. Davie, E. Seto, R.N. Eisenman, Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression, Cell 89 (1997) 349-356.
46. L. Nagy, H.-Y. Kao, D. Chakravarti, R.J. Lin, C.A. Hassig, D.E. Ayer, S.L. Schreiber, R.M. Evans, Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase, Cell 89 (1997) 373-380.
47. Y. Zhang, R. Iratni, H. Erdjument-Bromage, P. Tempst, D. Reinberg, Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex, Cell 89 (1997) 357-364.
48. A.P. Wolffe, D. Pruss, Targeting chromatin disruption: transcription regulators that acetylate histones, Cell 84 (1996) 817-819.
49. M. Grunstein, Histone acetylation in chromatin structure and transcription, Nature 389 (1997) 349-352.
50. A.P. Wolffe, Sinful repression, Nature 387 (1997) 16-17.
51. P.L. Jones, G.J.C. Vennstra, P.A. Wade, D. Vermaak, S.U. Kass, N. Landsberger, J. Strouboulis, A.P. Wolffe, Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription, Nature Genet. 19 (1998) 187-191.
52. X. Nan, H.-H. Ng, C.A. Johnson, C.D. Laherty, B.M. Turner, R.N. Eisenman, A. Bird, Transcriptional repression by the methyl-CpG binding protein MeCP2 involves a histone deacetylase complex, Nature 393 (1998) 386-389.
53. N. Schreiber-Agus, Y. Meng, T. Hoang, H. Hou Jr., K. Chen, R. Greenberg, C. Cordon-Cardo, H.-W. Lee, R.A. DePinho, Role of Mxil in ageing organ systems and the regulation of normal and neoplastic growth, Nature 393 (1998) 483-487.
54. A.-O. Hueber, G.I. Evan, Traps to catch unwary oncogenes, Trends Genet. 14 (1998) 364-367.
55. D. Metcalf, The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells, Nature 339 (1989) 27-30.
56. D. Metcalf, G.J. Lindeman, N.A. Nicola, Analysis of hematopoiesis in max41 transgenic mice that exhibit sustained elevations of blood granulocytes and monocytes, Blood 85 (1995) 2364-2370.
57. S.L. McKenna, T.G. Cotter, Functional aspects of apoptosis in hematopoiesis and consequences of failure, Adv. Cancer Res. 71 (1997) 121-164.
58. B.R. Stanton, A.S. Perkins, L. Tessarollo, D.A. Sassoon, L.F. Parada, Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop, Gene Dev. 6 (1993) 2235-2247.
59. P. Leder, J. Battey, G. Lenoir, C. Moulding, W. Murphy, H. Potter, T. Stewart, R. Taub, Translocations among antibody genes in human cancer, Science 222 (1983) 765-771.
60. J. Lanoix, V. D'Agati, M. Szabolcs, M. Trudel, Deregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease, Oncogene 13 (1996) 1153-1160.
61. M. Trudel, L. Barisoni, J. Lanoix, V. D'Agati, Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression, Am. J. Pathol. 152 (1996) 219-229.
62. I. Magrath, The pathogenesis of Burkitt's lymphoma, Adv. Cancer Res. 55 (1990) 134-251.
63. D. Bartsch, S.L. Peiffer, Z. Kaleem, S.A. Wells Jr., P.J. Goodfellow, Mxil tumor suppressor gene is not mutated in primary pancreatic adenocarcinoma, Cancer Lett. 102 (1996) 73-76.
64. S.K. Kim, J.Y. Ro, B.L. Kemp, J.S. Lee, T.J. Kwon, W.K. Hong, L. Mao, Identification of two distinct tumor-suppressor loci on the long arm of chromosome 10 in small cell lung cancer, Oncogene 17 (1998) 1749-1753.
65. S.M. Edwards, D.P. Dearnaley, A. Ardern-Jones, R.A. Hamoudi, D.F. Easton, D. Ford, R. Shearer, A. Dowe, No germline mutations in the dimerization domain of MXIl in prostate cancer clusters, Br. J. Cancer 76 (1997) 992-1000.
66. N. Kawamata, D. Park, S. Wilczynski, J. Yokota, H.P. Koeffler, Point mutation of the Mxil gene are rare in prostate cancers, Prostate 29 (1996) 191-193.
67. D. Fults, C.A. Pedone, G.E. thompson, C.M. Uchiyama, K.L. Gumpper, D. Iliev, V.L. Vinson, S.V. Tavitigian, W.L.I. Perry, Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMACl, FAS, and MXIl in human glioblastoma multiform, Int. J. Oncol. 12 (1998) 905-910.
68. M.A. Kuczyk, J. Serth, C. Bokemeter, J. Schwede, R. Herrmann, S. Machtens, V. Grünewald, U. Jonas, The MXIl tumor suppressor gene is not mutated in primary prostate cancer, Oncol. Rep. 5 (1998) 213-216.
69. C. Grandori, R.N. Eisenman, Myc target genes, TIBS 22 (1997) 177-181.
70. A. Bush, M. Mateyak, K. Dugan, A. Obaya, S. Adachi, J. Sedivy, M. Cole, c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets, Genes Dev. 12 (1998) 3797-3802.